Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients.
Association between circulating fibroblast growth factor 23, α-Klotho, and the left ventricular ejection fraction and left ventricular mass in cardiology inpatients.
复制标题
DOI:
10.1371/journal.pone.0073184
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Ishizaka N
中科院分区:
文献类型:
--
作者:
Shibata K;Fujita S;Morita H;Okamoto Y;Sohmiya K;Hoshiga M;Ishizaka N
Fibroblast growth factor 23 (FGF23), with its co-receptor Klotho, plays a crucial role in phosphate metabolism. Several recent studies suggested that circulating FGF23 and α-Klotho concentrations might be related to cardiovascular abnormalities in patients with advanced renal failure. Using data from 100 cardiology inpatients who were not undergoing chronic hemodialysis, the association of circulating levels of FGF23, α-Klotho, and other calcium-phosphate metabolism-related parameters with the left ventricular ejection fraction (LVEF) and left ventricular mass (LVM) was analyzed. LVEF was measured using the modified Simpson method for apical 4-chamber LV images and the LVM index (LVMI) was calculated by dividing the LVM by body surface area. Univariate analysis showed that log transformed FGF23, but not that of α-Klotho, was significantly associated with LVEF and LVMI with a standardized beta of −0.35 (P<0.001) and 0.26 (P<0.05), respectively. After adjusting for age, sex, estimated glomerular filtration rate, and serum concentrations of intact parathyroid hormone, and 25-hydroxyvitamin D as covariates into the statistical model, log-transformed FGF23 was found to be a statistically positive predictor for decreased left ventricular function and left ventricular hypertrophy. In cardiology department inpatients, circulating FGF23 concentrations were found to be associated with the left ventricular mass and LVEF independent of renal function and other calcium-phosphate metabolism-related parameters. Whether modulation of circulating FGF23 levels would improve cardiac outcome in such a high risk population awaits further investigation.
登录
查看更多内容
影响因子:
3.7
作者:
Kitagawa M;Sugiyama H;Morinaga H;Inoue T;Takiue K;Ogawa A;Yamanari T;Kikumoto Y;Uchida HA;Kitamura S;Maeshima Y;Nakamura K;Ito H;Makino H
通讯作者:
Makino H
影响因子:
24
作者:
Kestenbaum, Bryan;Katz, Ronit;de Boer, Ian;Hoofnagle, Andy;Sarnak, Mark J.;Shlipak, Michael G.;Jenny, Nancy S.;Siscovick, David S.
通讯作者:
Siscovick, David S.
影响因子:
13.2
作者:
Matsuo, Seiichi;Imai, Enyu;Hishida, Akira
通讯作者:
Hishida, Akira
影响因子:
56.9
作者:
Kurosu, H;Yamamoto, M;Kuro-o, M
通讯作者:
Kuro-o, M
影响因子:
19.6
作者:
Arnlov, Johan;Carlsson, Axel C.;Larsson, Tobias E.
通讯作者:
Larsson, Tobias E.